Autopsy report · NCT02503735

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

“Unable to meet enrollment goal”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 10 months before it stopped.
• 14 participants enrolled.
• Results were posted on the registry 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Hepatitis C; Chronic Kidney Disease

Interventions

Sofosbuvir/Ledipasvir FDC

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions
  “Unable to meet enrollment goals” (97% match in meaning)
• Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
  “unable to meet the target enrollment goal” (91% match in meaning)
• Cervical Ripening in Postmenopausal Women
  “not able to meet enrollment” (89% match in meaning)
• Hearing Resources and Outcomes in the Emergency Department (HERO-ED)
  “Did not meet enrollment” (81% match in meaning)
• Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
  “insufficient enrollment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.